Baystate Wealth Management’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-735	Closed	-$1.66K	–	1090
2023 Q1	$1.66K	Hold	735	–	–	﹤0.01%	858
2022 Q4	$3K	Buy	+735	New	+$3K	﹤0.01%	757